Prawo i regulacje · 29/12/2017
Cambrex High Point, Inc. Files Application to Become Bulk Manufacturer of Controlled Substances
Cambrex High Point, Inc. has submitted a proposal to the U.S. Drug Enforcement Administration (DEA) to become a bulk manufacturer of controlled substances, a significant development in the pharmaceutical industry.